# Edaravone in the Treatment of Optic Neuritis

> **NCT05540262** · NA · RECRUITING · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Optic Neuritis

## Interventions

- **DRUG:** Edaravone

## Key facts

- **NCT ID:** NCT05540262
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540262, "Edaravone in the Treatment of Optic Neuritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05540262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*